Since its founding in 1990, the GRA has focused its technology-based economic development strategy in three areas: the recruitment of world-class scientific talent, the development of sophisticated research infrastructure and the commercialization of university research and development. In all, GRA’s programs have generated some $2.1 billion in new investment in the state, helped generate some more than 150 new companies and created more than 5,500 new science and technology jobs. (To learn more about biosciences in Georgia visit www.georgiabiosciences.com and http://lifesciences.georgiainnovation.org/.)

The heart and hub of the GRA strategy is the nationally-recognized GRA Eminent Scholars® program. Its purpose is to bring pre-eminent scientists to Georgia’s research universities and provide them with the tools they need to lead research and development programs with the greatest potential for generating significant economic gains for Georgia and Georgians. To date the program has recruited more than 60 GRA Eminent Scholars in diverse fields including vaccine development, molecular biotechnology, crop genomics, drug discovery, medical imaging, animal health and biomedical engineering.

VentureLabs at Georgia Tech, University of Georgia, Emory University, Clark Atlanta University, Medical College of Georgia and Georgia State help build high-growth companies around laboratory discoveries. They seek out research innovations at GRA’s partner universities, assesses their commercial potential, and provides resources to suitably address the management, market and technology risks associated with new venture formation.

To learn more about the GRA, visit them online or contact them.

Related Site: